Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.

Authors

Christopher R Heier, George Washington University
Qing Yu
Alyson A Fiorillo, George Washington University
Christopher B Tully
Asya Tucker
Davi A Mazala
Kitipong Uaesoontrachoon
Sadish Srinivassane
Jesse M Damsker
Eric P Hoffman
Kanneboyina Nagaraju
Christopher F Spurney, George Washington University

Document Type

Journal Article

Publication Date

2-1-2019

Journal

Life Science Alliance

Volume

2

Issue

1

DOI

10.26508/lsa.201800186

APA Citation

Heier, C., Yu, Q., Fiorillo, A., Tully, C., Tucker, A., Mazala, D., Uaesoontrachoon, K., Srinivassane, S., Damsker, J., Hoffman, E., Nagaraju, K., & Spurney, C. (2019). Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.. Life Science Alliance, 2 (1). http://dx.doi.org/10.26508/lsa.201800186

Peer Reviewed

1